Effects of losartan and captopril on QT dispersion in elderly patients with heart failure

被引：28

作者：

Brooksby, P

Robinson, PJ

Segal, R

Klinger, G

Pitt, B

Cowley, AJC

机构：

[1] Univ Nottingham Hosp, Queens Med Ctr, Dept Cardiovasc Med, Nottingham NG7 2UH, England

[2] Merck Res Labs, W Point, PA USA

[3] Merck Sharpe & Dohme UK, Hoddesdon, Herts, England

[4] Univ Michigan Hosp, Div Cardiol, Ann Arbor, MI 48109 USA

来源：

LANCET | 1999年 / 354卷 / 9176期

关键词：

D O I：

10.1016/S0140-6736(99)01354-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Differences in QT dispersion (a predictor for sudden death) were observed In a subgroup of patients in the ELITE heart failure study of losartan compared with captopril, and may explain improved survival with losartan.

引用

页码：395 / 396

页数：2

共 5 条

[1] QT DISPERSION AND SUDDEN UNEXPECTED DEATH IN CHRONIC HEART-FAILURE [J].

BARR, CS ;

NAAS, A ;

FREEMAN, M ;

LANG, CC ;

STRUTHERS, AD .

LANCET, 1994, 343 (8893) :327-329

[2]

LYNCH JJ, IN PRESS J AM COLL C

[3] Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) [J].

Pitt, B ;

Segal, R ;

Martinez, FA ;

Meurers, G ;

Cowley, AJ ;

Thomas, I ;

Deedwania, PC ;

Ney, DE ;

Snavely, DB ;

Chang, PI .

LANCET, 1997, 349 (9054) :747-752

[4] Experimental evidence to support ELITE [J].

Rump, LC ;

Oberhauser, V ;

Schwertfeger, E ;

Schollmeyer, P .

LANCET, 1998, 351 (9103) :644-645

[5]

Thomas GP, 1996, J PHARMACOL EXP THER, V278, P1090

← 1 →